Rockwell Medical Inc (NASDAQ:RMTI) — Market Cap & Net Worth
Market Cap & Net Worth: Rockwell Medical Inc (RMTI)
Rockwell Medical Inc (NASDAQ:RMTI) has a market capitalization of $25.68 Million ($25.68 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #24347 globally and #5160 in its home market, demonstrating a -5.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rockwell Medical Inc's stock price $0.65 by its total outstanding shares 39470299 (39.47 Million). Review Rockwell Medical Inc (RMTI) financial obligations to assess the company's total debt and financial obligations.
Rockwell Medical Inc Market Cap History: 2015 to 2026
Rockwell Medical Inc's market capitalization history from 2015 to 2026. Data shows change from $4.45 Billion to $25.68 Million (-39.49% CAGR).
Index Memberships
Rockwell Medical Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.00% | #697 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #2296 of 3165 |
Weight: Rockwell Medical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Rockwell Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rockwell Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.48x
Rockwell Medical Inc's market cap is 0.48 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.84 Billion | $53.28 Million | -$19.80 Million | 53.37x | N/A |
| 2017 | $2.53 Billion | $57.30 Million | -$25.92 Million | 44.10x | N/A |
| 2018 | $981.23 Million | $63.39 Million | -$32.13 Million | 15.48x | N/A |
| 2019 | $1.06 Billion | $61.30 Million | -$34.13 Million | 17.28x | N/A |
| 2020 | $438.52 Million | $62.20 Million | -$30.89 Million | 7.05x | N/A |
| 2021 | $178.01 Million | $61.93 Million | -$32.67 Million | 2.87x | N/A |
| 2022 | $40.06 Million | $72.81 Million | -$18.68 Million | 0.55x | N/A |
| 2023 | $74.60 Million | $83.61 Million | -$8.44 Million | 0.89x | N/A |
| 2024 | $80.52 Million | $101.49 Million | -$480.00K | 0.79x | N/A |
| 2025 | $32.90 Million | $69.26 Million | -$5.31 Million | 0.48x | N/A |
Competitor Companies of RMTI by Market Capitalization
Companies near Rockwell Medical Inc in the global market cap rankings as of June 18, 2026.
Key companies related to Rockwell Medical Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #631 globally with a market cap of $43.86 Billion USD ( CN¥299.75 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #634 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.27 |
| #631 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $43.86 Billion | CN¥46.99 |
| #634 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
Rockwell Medical Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Rockwell Medical Inc's market cap moved from $4.45 Billion to $ 25.68 Million, with a yearly change of -39.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $25.68 Million | -21.96% |
| 2025 | $32.90 Million | -59.14% |
| 2024 | $80.52 Million | +7.94% |
| 2023 | $74.60 Million | +86.21% |
| 2022 | $40.06 Million | -77.49% |
| 2021 | $178.01 Million | -59.41% |
| 2020 | $438.52 Million | -58.61% |
| 2019 | $1.06 Billion | +7.96% |
| 2018 | $981.23 Million | -61.17% |
| 2017 | $2.53 Billion | -11.15% |
| 2016 | $2.84 Billion | -36.04% |
| 2015 | $4.45 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Rockwell Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $25.68 Million USD |
| MoneyControl | $25.68 Million USD |
| MarketWatch | $25.68 Million USD |
| marketcap.company | $25.68 Million USD |
| Reuters | $25.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Rockwell Medical Inc
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate conce… Read more